Status:
UNKNOWN
Red Palm Olein and Cardiovascular Health
Lead Sponsor:
Malaysia Palm Oil Board
Conditions:
Cardiovascular Risk Factor
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Red palm oil is obtained from crude palm oil through a novel low-temperature process. Owing to this special process, RPO possesses a special flavour and aroma, and is rich in phytonutrients that inclu...
Detailed Description
The oil palm Elaeis guineesis, is the source of palm oil - the 'tropical golden oil'. Malaysia is the world's largest exporter of this golden oil. Triglycerides constitute the major component of crude...
Eligibility Criteria
Inclusion
- Abdominally obese males and females (waist circumference \> 90 cm for male, \> 80 cm for female), age between 20-60 years and BMI ≥18.5kgm2 will be recruited.
Exclusion
- Medical history of myocardial infarction, angina, thrombosis, stroke, cancer or diabetes
- Blood glucose; \>7.0 mmol/L
- Serum triacylglycerol; \>4.5 mmol/L
- Serum total cholesterol; \>6.5 mmol/L
- Body mass index \<18.5 kg/m2
- Current use of antihypertensive or lipid lowering medication
- Alcohol intake exceeding a moderate intake (\>28 units per week)
- Breastfeeding or pregnant
- Consume supplement such as herbs and hormone pills
- Smoking
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT02263183
Start Date
January 1 2013
End Date
December 1 2017
Last Update
September 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Malaysia Palm Oil Board
Kajang, Selangor, Malaysia, 50720